RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000075.xml
PDF herunterladen
Semin Respir Crit Care Med 2016; 37(02): 303-317
DOI: 10.1055/s-0036-1572561
DOI: 10.1055/s-0036-1572561
Critical Care in Human Immunodeficiency Virus–Infected Patients
Weitere Informationen
Publikationsverlauf
Publikationsdatum:
14. März 2016 (online)
Abstract
Intensive care unit (ICU) survival has been improved significantly for HIV-infected patients since the advent of antiretroviral therapy (ART). Non-AIDS conditions account for the majority of ICU admission diagnoses in areas with access to ART. However, opportunistic infections such as Pneumocystis jirovecii pneumonia still account for a significant proportion of ICU admissions, particularly in newly diagnosed HIV-infected patients, and are associated with increased ICU mortality. We discuss risk factors and outcomes for HIV-infected admitted to the ICU in the current ART era. We review the changing patterns in ICU admission diagnoses over time and how common ICU conditions are managed in HIV-infected compared with uninfected patients. We next address issues specific to the care for HIV-infected patients in the ICU, focusing on immune reconstitution inflammatory syndrome, ART continuation or initiation, and some common and potentially life-threatening ART-associated toxicities.
-
References
- 1 Crothers K, Huang L, Goulet JL , et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011; 183 (3) 388-395
- 2 Freiberg MS, Chang CC, Kuller LH , et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173 (8) 614-622
- 3 Sigel K, Wisnivesky J, Gordon K , et al. HIV as an independent risk factor for incident lung cancer. AIDS 2012; 26 (8) 1017-1025
- 4 Wyatt CM, Arons RR, Klotman PE, Klotman ME. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS 2006; 20 (4) 561-565
- 5 Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome. Outcome and changing patterns of utilization. Am Rev Respir Dis 1986; 134 (5) 891-896
- 6 Schein RM, Fischl MA, Pitchenik AE, Sprung CL. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med 1986; 14 (12) 1026-1027
- 7 De Palo VA, Millstein BH, Mayo PH, Salzman SH, Rosen MJ. Outcome of intensive care in patients with HIV infection. Chest 1995; 107 (2) 506-510
- 8 Wachter RM, Russi MB, Bloch DA, Hopewell PC, Luce JM. Pneumocystis carinii pneumonia and respiratory failure in AIDS. Improved outcomes and increased use of intensive care units. Am Rev Respir Dis 1991; 143 (2) 251-256
- 9 Bozzette SA, Sattler FR, Chiu J , et al; California Collaborative Treatment Group. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990; 323 (21) 1451-1457
- 10 Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004; 125 (5) 1800-1804
- 11 Nuesch R, Geigy N, Schaedler E, Battegay M. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21 (9) 684-687
- 12 Akgün KM, Pisani M, Crothers K. The changing epidemiology of HIV-infected patients in the intensive care unit. J Intensive Care Med 2011; 26 (3) 151-164
- 13 Akgün KM, Tate JP, Pisani M , et al. Medical ICU admission diagnoses and outcomes in human immunodeficiency virus-infected and virus-uninfected veterans in the combination antiretroviral era. Crit Care Med 2013; 41 (6) 1458-1467
- 14 Palacios R, Hidalgo A, Reina C, de la Torre M, Márquez M, Santos J. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med 2006; 7 (3) 193-196
- 15 Justice AC, Dombrowski E, Conigliaro J , et al. Veterans Aging Cohort Study (VACS): overview and description. Med Care 2006; 44 (8) (Suppl. 02) S13-S24
- 16 Oursler KK, Goulet JL, Leaf DA , et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 2006; 20 (11) 782-791
- 17 Barbier F, Roux A, Canet E , et al. Temporal trends in critical events complicating HIV infection: 1999-2010 multicentre cohort study in France. Intensive Care Med 2014; 40 (12) 1906-1915
- 18 Khouli H, Afrasiabi A, Shibli M, Hajal R, Barrett CR, Homel P. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005; 20 (6) 327-333
- 19 Vincent B, Timsit JF, Auburtin M , et al. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med 2004; 30 (5) 859-866
- 20 Powell K, Davis JL, Morris AM, Chi A, Bensley MR, Huang L. Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009; 135 (1) 11-17
- 21 Akgün KM, Gordon K, Pisani M , et al. Risk factors for hospitalization and medical intensive care unit (MICU) admission among HIV-infected Veterans. J Acquir Immune Defic Syndr 2013; 62 (1) 52-59
- 22 Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002; 166 (3) 262-267
- 23 Rosen MJ, Clayton K, Schneider RF , et al; Pulmonary Complications of HIV Infection Study Group. Intensive care of patients with HIV infection: utilization, critical illnesses, and outcomes. Am J Respir Crit Care Med 1997; 155 (1) 67-71
- 24 Gill JK, Greene L, Miller R , et al. ICU admission in patients infected with the human immunodeficiency virus - a multicentre survey. Anaesthesia 1999; 54 (8) 727-732
- 25 Dickson SJ, Batson S, Copas AJ, Edwards SG, Singer M, Miller RF. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 2007; 62 (11) 964-968
- 26 Miller RF, Allen E, Copas A, Singer M, Edwards SG. Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy. Thorax 2006; 61 (8) 716-721
- 27 Finfer S, Chittock DR, Su SY , et al; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360 (13) 1283-1297
- 28 Medrano J, Álvaro-Meca A, Boyer A, Jiménez-Sousa MA, Resino S. Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis. Crit Care 2014; 18 (4) 475
- 29 Adlakha A, Pavlou M, Walker DA , et al. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy. Int J STD AIDS 2011; 22 (9) 498-504
- 30 Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000; 118 (1) 138-145
- 31 Coquet I, Pavie J, Palmer P , et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 2010; 14 (3) R107
- 32 Croda J, Croda MG, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009; 37 (5) 1605-1611
- 33 Nickas G, Wachter RM. Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 2000; 160 (4) 541-547
- 34 Amâncio FF, Lambertucci JR, Cota GF, Antunes CM. Predictors of the short- and long-term survival of HIV-infected patients admitted to a Brazilian intensive care unit. Int J STD AIDS 2012; 23 (10) 692-697
- 35 Bonarek M, Morlat P, Chêne G , et al. Prognostic score of short-term survival in HIV-infected patients admitted to medical intensive care units. Int J STD AIDS 2001; 12 (4) 239-244
- 36 Casalino E, Mendoza-Sassi G, Wolff M , et al. Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998; 113 (2) 421-429
- 37 Chiang HH, Hung CC, Lee CM , et al. Admissions to intensive care unit of HIV-infected patients in the era of highly active antiretroviral therapy: etiology and prognostic factors. Crit Care 2011; 15 (4) R202
- 38 Turtle L, Vyakernam R, Menon-Johansson A, Nelson MR, Soni N. Intensive care usage by HIV-positive patients in the HAART era. Interdiscip Perspect Infect Dis 2011; 2011: 847835
- 39 Xiao J, Zhang W, Huang Y , et al. Etiology and outcomes for patients infected with HIV in intensive care units in a tertiary care hospital in China. J Med Virol 2015; 87 (3) 366-374
- 40 Silva Jr JM, dos Santos SdeS. Sepsis in AIDS patients: clinical, etiological and inflammatory characteristics. J Int AIDS Soc 2013; 16: 17344
- 41 Cribbs SK, Tse C, Andrews J, Shenvi N, Martin GS. Characteristics and outcomes of HIV-infected patients with severe sepsis: continued risk in the Post-Highly Active Antiretroviral Therapy Era. Crit Care Med 2015; 43 (8) 1638-1645
- 42 Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004; 18 (10) 1429-1433
- 43 Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM , et al. Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res 2007; 38 (8) 827-833
- 44 Barbier F, Coquet I, Legriel S , et al. Etiologies and outcome of acute respiratory failure in HIV-infected patients. Intensive Care Med 2009; 35 (10) 1678-1686
- 45 Morris A, Wachter RM, Luce J, Turner J, Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003; 17 (1) 73-80
- 46 The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1301-1308
- 47 Frat JP, Thille AW, Mercat A , et al; FLORALI Study Group; REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372 (23) 2185-2196
- 48 Confalonieri M, Calderini E, Terraciano S , et al. Noninvasive ventilation for treating acute respiratory failure in AIDS patients with Pneumocystis carinii pneumonia. Intensive Care Med 2002; 28 (9) 1233-1238
- 49 Anjos CF, Schettino GP, Park M, Souza VS, Scalabrini Neto A. A randomized trial of noninvasive positive end expiratory pressure in patients with acquired immune deficiency syndrome and hypoxemic respiratory failure. Respir Care 2012; 57 (2) 211-220
- 50 Miller RF, Semple SJ. Continuous positive airway pressure ventilation for respiratory failure associated with Pneumocystis carinii pneumonia. Respir Med 1991; 85 (2) 133-138
- 51 Dellinger RP, Levy MM, Rhodes A , et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41 (2) 580-637
- 52 Rivers E, Nguyen B, Havstad S , et al; Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345 (19) 1368-1377
- 53 Friis-Møller N, Sabin CA, Weber R , et al; Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349 (21) 1993-2003
- 54 Remick J, Georgiopoulou V, Marti C , et al. Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation 2014; 129 (17) 1781-1789
- 55 Huang L, Quartin A, Jones D, Havlir DV. Intensive care of patients with HIV infection. N Engl J Med 2006; 355 (2) 173-181
- 56 Chen TY, Ding EL, Seage Iii GR, Kim AY. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009; 49 (10) 1605-1615
- 57 Smit C, Geskus R, Walker S , et al; CASCADE Collaboration. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 2006; 20 (5) 741-749
- 58 van Lelyveld SF, Wind CM, Mudrikova T, van Leeuwen HJ, de Lange DW, Hoepelman AI. Short- and long-term outcome of HIV-infected patients admitted to the intensive care unit. Eur J Clin Microbiol Infect Dis 2011; 30 (9) 1085-1093
- 59 Leifeld L, Rockstroh J, Skaide S , et al. Indication, outcome and follow up of intensive care in patients with HIV-infection. Eur J Med Res 2000; 5 (5) 199-202
- 60 Franzetti F, Grassini A, Piazza M , et al. Nosocomial bacterial pneumonia in HIV-infected patients: risk factors for adverse outcome and implications for rational empiric antibiotic therapy. Infection 2006; 34 (1) 9-16
- 61 Nirappil FJ, Maheshwari A, Andrews J, Martin GS, Esper AM, Cribbs SK. Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome. J Crit Care 2015; 30 (1) 60-64
- 62 Alves C, Nicolás JM, Miró JM , et al. Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J 2001; 17 (1) 87-93
- 63 Radhi S, Alexander T, Ukwu M, Saleh S, Morris A. Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003. BMC Infect Dis 2008; 8: 118
- 64 Fei MW, Sant CA, Kim EJ , et al. Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study. Scand J Infect Dis 2009; 41 (9) 672-678
- 65 Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006. Clin Infect Dis 2008; 46 (4) 625-633
- 66 Bédos JP, Dumoulin JL, Gachot B , et al. Pneumocystis carinii pneumonia requiring intensive care management: survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med 1999; 27 (6) 1109-1115
- 67 Armstrong-James D, Copas AJ, Walzer PD, Edwards SG, Miller RF. A prognostic scoring tool for identification of patients at high and low risk of death from HIV-associated Pneumocystis jirovecii pneumonia. Int J STD AIDS 2011; 22 (11) 628-634
- 68 Fei MW, Kim EJ, Sant CA , et al. Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax 2009; 64 (12) 1070-1076
- 69 Sax PE, Komarow L, Finkelman MA , et al; AIDS Clinical Trials Group Study A5164 Team. Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis 2011; 53 (2) 197-202
- 70 Golden JA, Hollander H, Stulbarg MS, Gamsu G. Bronchoalveolar lavage as the exclusive diagnostic modality for Pneumocystis carinii pneumonia. A prospective study among patients with acquired immunodeficiency syndrome. Chest 1986; 90 (1) 18-22
- 71 Miller RF, Millar AB, Weller IV, Semple SJ. Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Thorax 1989; 44 (7) 559-564
- 72 Ahmad A, Khan S, Soubani AO. The findings of surgical lung biopsy in HIV patients in the era of highly active antiretroviral therapy. Ann Thorac Surg 2005; 79 (6) 1862-1865
- 73 Benfield T, Atzori C, Miller RF, Helweg-Larsen J. Second-line salvage treatment of AIDS-associated Pneumocystis jirovecii pneumonia: a case series and systematic review. J Acquir Immune Defic Syndr 2008; 48 (1) 63-67
- 74 Helweg-Larsen J, Benfield T, Atzori C, Miller RF. Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. J Antimicrob Chemother 2009; 64 (6) 1282-1290
- 75 Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H ; Centers for Disease Control and Prevention (CDC); National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58 (RR-4, RR04): 1-207 , quiz CE1–CE4
- 76 Benito N, Moreno A, Miro JM, Torres A. Pulmonary infections in HIV-infected patients: an update in the 21st century. Eur Respir J 2012; 39 (3) 730-745
- 77 Rubaihayo J, Tumwesigye NM, Konde-Lule J. Trends in prevalence of diarrhoea, Kaposi's sarcoma, bacterial pneumonia, malaria and geohelminths among HIV positive individuals in Uganda. AIDS Res Ther 2015; 12: 20
- 78 Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117 (4) 1017-1022
- 79 Barakat LA, Juthani-Mehta M, Allore H , et al. Comparing clinical outcomes in HIV-infected and uninfected older men hospitalized with community-acquired pneumonia. HIV Med 2015; 16 (7) 421-430
- 80 Segal LN, Methé BA, Nolan A , et al. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 2011; 8 (3) 282-287
- 81 Sogaard OS, Lohse N, Gerstoft J , et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis 2008; 47 (10) 1345-1353
- 82 Hirschtick RE, Glassroth J, Jordan MC , et al; Pulmonary Complications of HIV Infection Study Group. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333 (13) 845-851
- 83 Feikin DR, Feldman C, Schuchat A, Janoff EN. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4 (7) 445-455
- 84 Perelló R, Miró O, Marcos MA , et al. Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED. Am J Emerg Med 2010; 28 (4) 454-459
- 85 Madeddu G, Laura Fiori M, Stella Mura M. Bacterial community-acquired pneumonia in HIV-infected patients. Curr Opin Pulm Med 2010; 16 (3) 201-207
- 86 Allen CM, Al-Jahdali HH, Irion KL, Al Ghanem S, Gouda A, Khan AN. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med 2010; 5 (4) 201-216
- 87 McGuinness G. Changing trends in the pulmonary manifestations of AIDS. Radiol Clin North Am 1997; 35 (5) 1029-1082
- 88 Rizzi EB, Schinina V, Bellussi A , et al. Pulmonary mycosis in AIDS. Eur J Radiol 2001; 37 (1) 42-46
- 89 Greenberg SD, Frager D, Suster B, Walker S, Stavropoulos C, Rothpearl A. Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance). Radiology 1994; 193 (1) 115-119
- 90 Tokman S, Huang L. Evaluation of respiratory disease. Clin Chest Med 2013; 34 (2) 191-204
- 91 American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171 (4) 388-416
- 92 Mandell LA, Wunderink RG, Anzueto A , et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl. 02) S27-S72
- 93 Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001; 29 (3) 548-556
- 94 Greenberg JA, Lennox JL, Martin GS. Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy. J Crit Care 2012; 27 (1) 51-57
- 95 Jacob ST, Moore CC, Banura P , et al; Promoting Resource-Limited Interventions for Sepsis Management in Uganda (PRISM-U) Study Group. Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population. PLoS ONE 2009; 4 (11) e7782
- 96 Jacob ST, Pavlinac PB, Nakiyingi L , et al. Mycobacterium tuberculosis bacteremia in a cohort of HIV-infected patients hospitalized with severe sepsis in Uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. PLoS ONE 2013; 8 (8) e70305
- 97 Japiassú AM, Amâncio RT, Mesquita EC , et al. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 2010; 14 (4) R152
- 98 Mrus JM, Braun L, Yi MS, Linde-Zwirble WT, Johnston JA. Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005; 9 (6) R623-R630
- 99 Marik PE, Kiminyo K, Zaloga GP. Adrenal insufficiency in critically ill patients with human immunodeficiency virus. Crit Care Med 2002; 30 (6) 1267-1273
- 100 Ben-Shlomo A, Mirocha J, Gwin SM , et al. Clinical factors associated with biochemical adrenal-cortisol insufficiency in hospitalized patients. Am J Med 2014; 127 (8) 754-762
- 101 Morquin D, Le Moing V, Mura T , et al. Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status. Ann Intensive Care 2012; 2 (1) 25
- 102 Terrault NA, Roland ME, Schiano T , et al; Solid Organ Transplantation in HIV: Multi-Site Study Investigators. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 2012; 18 (6) 716-726
- 103 Choi AI, Li Y, Parikh C, Volberding PA, Shlipak MG. Long-term clinical consequences of acute kidney injury in the HIV-infected. Kidney Int 2010; 78 (5) 478-485
- 104 Randall D, Brima N, Walker D , et al. Acute kidney injury among HIV-infected patients admitted to the intensive care unit. Int J STD AIDS 2015; 26 (13) 915-921
- 105 Abraham AG, Althoff KN, Jing Y , et al; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA). End-stage renal disease among HIV-infected adults in North America. Clin Infect Dis 2015; 60 (6) 941-949
- 106 Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR. The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis. AIDS 2008; 22 (14) 1799-1807
- 107 Grinspoon SK, Bilezikian JP. HIV disease and the endocrine system. N Engl J Med 1992; 327 (19) 1360-1365
- 108 Kibirige D, Ssekitoleko R. Endocrine and metabolic abnormalities among HIV-infected patients: a current review. Int J STD AIDS 2013; 24 (8) 603-611
- 109 Foisy MM, Yakiwchuk EM, Chiu I, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 2008; 9 (6) 389-396
- 110 Yombi JC, Maiter D, Belkhir L, Nzeusseu A, Vandercam B. Iatrogenic Cushing's syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol 2008; 27 (Suppl. 02) S79-S82
- 111 Chattha G, Arieff AI, Cummings C, Tierney Jr LM. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118 (1) 37-39
- 112 Claessens YE, Cariou A, Monchi M , et al. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Crit Care Med 2003; 31 (4) 1042-1047
- 113 Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993; 7 (3) 379-385
- 114 Margolis AM, Heverling H, Pham PA, Stolbach A. A review of the toxicity of HIV medications. J Med Toxicol 2014; 10 (1) 26-39
- 115 Tan DH, Walmsley SL. Management of persons infected with human immunodeficiency virus requiring admission to the intensive care unit. Crit Care Clin 2013; 29 (3) 603-620
- 116 Claessens YE, Cariou A, Chiche JD, Dauriat G, Dhainaut JF. L-Carnitine as a treatment of life-threatening lactic acidosis induced by nucleoside analogues. AIDS 2000; 14 (4) 472-473
- 117 Brinkman K, Vrouenraets S, Kauffmann R, Weigel H, Frissen J. Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis. AIDS 2000; 14 (17) 2801-2802
- 118 Fouty B, Frerman F, Reves R. Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet 1998; 352 (9124) 291-292
- 119 Mimoz O, Binter V, Jacolot A , et al. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Med 1998; 24 (10) 1047-1051
- 120 Heyland DK, Tougas G, King D, Cook DJ. Impaired gastric emptying in mechanically ventilated, critically ill patients. Intensive Care Med 1996; 22 (12) 1339-1344
- 121 Tarling MM, Toner CC, Withington PS, Baxter MK, Whelpton R, Goldhill DR. A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med 1997; 23 (3) 256-260
- 122 Hart D, Sayer R, Miller R , et al. Human immunodeficiency virus associated thrombotic thrombocytopenic purpura—favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy. Br J Haematol 2011; 153 (4) 515-519
- 123 El-Sadr WM, Lundgren J, Neaton JD , et al; Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006; 355 (22) 2283-2296
- 124 Arenas-Pinto A, Thompson J, Musoro G , et al; EARNEST Trial Team. Peripheral neuropathy in HIV patients in sub-Saharan Africa failing first-line therapy and the response to second-line ART in the EARNEST trial. J Neurovirol 2015;
- 125 Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M ; IeDEA Southern and Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10 (4) 251-261
- 126 https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf . Last accessed September 15, 2015
- 127 Zolopa A, Andersen J, Powderly W , et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS ONE 2009; 4 (5) e5575
- 128 Abay SM, Deribe K, Reda AA , et al. The effect of early initiation of antiretroviral therapy in TB/HIV-coinfected patients: a systematic review and meta-analysis. J Int Assoc Provid AIDS Care 2015; 14 (6) 560-570
- 129 Ganesan A, Masur H. Critical care of persons infected with the human immunodeficiency virus. Clin Chest Med 2013; 34 (2) 307-323
- 130 Buckingham SJ, Haddow LJ, Shaw PJ, Miller RF. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clin Radiol 2004; 59 (6) 505-513
- 131 Bell LC, Breen R, Miller RF, Noursadeghi M, Lipman M. Paradoxical reactions and immune reconstitution inflammatory syndrome in tuberculosis. Int J Infect Dis 2015; 32: 39-45
- 132 Nyberg CR, Patterson BY, Williams MM. When patients cannot take pills: antiretroviral drug formulations for managing adult HIV infection. Top Antivir Med 2011; 19 (3) 126-131
- 133 Prohaska ES, King AR. Administration of antiretroviral medication via enteral tubes. Am J Health Syst Pharm 2012; 69 (24) 2140-2146
- 134 Sandkovsky U, Swindells S, Moore R, Acosta EP, Fletcher CV. Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection. Pharmacotherapy 2012; 32 (2) 142-147